In 2020, AstraZeneca paid a total of 39 billion U.S. dollars in upfront cash and equity for merger and acquisition deals, while Gilead paid nearly 28 billion U.S. dollars. This statistic illustrates the top buyers in biopharma therapeutics and platforms, diagnostics, and medtech (also digital health) merger and acquisition deals worldwide in 2020, by upfront cash and equity paid.
Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid*
(in billion U.S. dollars)
Characteristic
Upfront cash and equity in billion U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DealForma. (February 17, 2021). Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars) [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma. "Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars)." Chart. February 17, 2021. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma. (2021). Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars). Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma. "Leading Buyers in Biopharma, Diagnostics, and Medtech M&a Deals Worldwide in 2020, by Upfront Cash and Equity Paid* (in Billion U.S. Dollars)." Statista, Statista Inc., 17 Feb 2021, https://www.statista.com/statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/
DealForma, Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/ (last visited July 22, 2024)
Leading buyers in biopharma, diagnostics, and medtech M&A deals worldwide in 2020, by upfront cash and equity paid* (in billion U.S. dollars) [Graph], DealForma, February 17, 2021. [Online]. Available: https://www.statista.com/statistics/1240320/top-buyers-biopharma-ma-deals-by-upfront-cash-and-equity-paid/